Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's Dealings and Grant of Options

17 Nov 2017 14:24

RNS Number : 8699W
Proxama PLC
17 November 2017
 

17 November 2017

Proxama PLC

("Proxama" or the "Company")

Director's Dealings and Grant of Options

Director's Dealings

Proxama PLC, (AIM: PROX), the leading mobile location and data intelligence expert, announces that its Chief Executive Officer, Mark Slade, purchased 76,000,000 ordinary shares of 0.01p in the Company ("Ordinary Shares") at a price of 0.0265p per share on 16 November 2017. Following this purchase, Mark Slade now holds a total of 176,000,000 ordinary shares in the company representing 1.28% of the current issued share capital of the Company.

Grant of Options

On 14 November 2017, options over Ordinary Shares were granted to three directors with an exercise price of 0.03p as detailed below. These are exercisable, subject to performance criteria, after three years and within ten years of grant.

Mark Slade: 549,829,880

Dan Francis: 175,708,610

Kelvin Harrison: 66,666,667

Mark Slade has been granted an additional 687,287,350 options over the Company's Ordinary Shares, with an exercise price of 0.03p and subject to separate performance criteria, which are also exercisable after three years and within ten years of grant.

The Company has a total of 13,745,747,069 Ordinary Shares in issue with options granted over a further 1,562,740,546 Ordinary Shares. In addition Darwin holds 558,352,249 warrants at an exercise price of 0.1692 pence per share and Barclays holds 5,863,021,931 warrants at an exercise price of 0.03 pence per share.

 

 

Enquiries:

Proxama PLC

Mark Slade, Chief Executive Officer Via Redleaf Communications

 

Peel Hunt LLP 020 7418 8900

(Nominated Adviser and Broker)

Edward Knight/Nick Prowting

 

Redleaf Communications

Charlie Geller 020 7382 4769

Fiona Norman

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Slade

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Proxama Plc

b)

LEI

213800MKYV25HW2IAX70

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.01p

 

 

ISIN: GB00B2PKZ581

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.0265p

76,000,000

d)

Aggregated information

- Aggregated volume

- Price

 

176,000,000

0.03p / 0.0265p

e)

Date of the transaction

16 November 2017

f)

Place of the transaction

London Stock Exchange

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Slade

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Proxama Plc

b)

LEI

213800MKYV25HW2IAX70

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.01p

 

 

ISIN: GB00B2PKZ581

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.03p

0.03p

549,829,880

687,287,350

d)

Aggregated information

- Aggregated volume

- Price

 

1,237,117,230

0.03p

e)

Date of the transaction

14 November 2017

f)

Place of the transaction

London Stock Exchange

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dan Francis

2

Reason for the notification

a)

Position/status

Chief Strategy Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Proxama Plc

b)

LEI

213800MKYV25HW2IAX70

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.01p

 

 

ISIN: GB00B2PKZ581

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.03p

175,708,610

d)

Aggregated information

- Aggregated volume

- Price

 

175,708,610

0.03p

e)

Date of the transaction

14 November 2017

f)

Place of the transaction

London Stock Exchange

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kelvin Harrison

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Proxama Plc

b)

LEI

213800MKYV25HW2IAX70

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.01p

 

 

ISIN: GB00B2PKZ581

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.03p

66,666,667

d)

Aggregated information

- Aggregated volume

- Price

 

66,666,667

0.03p

e)

Date of the transaction

14 November 2017

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUBUSRBOAAAAA
Date   Source Headline
1st Jun 20207:00 amRNSIssue of Equity and Total Voting Rights
11th May 20201:51 pmRNSHolding(s) in Company
11th May 20201:50 pmRNSHolding(s) in Company
7th May 20202:06 pmRNSSecond Price Monitoring Extn
7th May 20202:00 pmRNSPrice Monitoring Extension
6th May 202010:42 amRNSIssue of Equity and Total Voting Rights
1st May 20202:06 pmRNSSecond Price Monitoring Extn
1st May 20202:00 pmRNSPrice Monitoring Extension
29th Apr 202011:06 amRNSSecond Price Monitoring Extn
29th Apr 202011:01 amRNSPrice Monitoring Extension
20th Apr 20203:16 pmRNSIssue of Equity and Total Voting Rights
9th Apr 202012:17 pmRNSResult of AGM
9th Apr 20207:00 amRNSAGM statement
8th Apr 202010:11 amRNSHolding(s) in Company
3rd Apr 20202:06 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSAttendance at the Company’s AGM
1st Apr 20204:45 pmRNSHolding(s) in Company
31st Mar 202010:12 amRNSHolding(s) in Company
31st Mar 202010:10 amRNSHolding(s) in Company
26th Mar 202011:50 amRNSResult of GM, Appointment of Joint Broker and TVR
26th Mar 20207:00 amRNSIssue of Warrants
23rd Mar 202012:00 pmRNSCovid-19 Update
16th Mar 20203:33 pmRNSNotice of GM
16th Mar 20207:00 amRNSAnnual Financial Report
6th Mar 20204:04 pmRNSConditional Placing and Share Re-organisation
3rd Mar 20207:00 amRNSGlobal Master Service Agreement and Partnership
28th Feb 20202:05 pmRNSSecond Price Monitoring Extn
28th Feb 20202:00 pmRNSPrice Monitoring Extension
26th Feb 20202:51 pmRNSStatement Regarding Share Price Movement
24th Jan 202010:09 amRNSHolding(s) in Company
23rd Jan 20207:00 amRNSReport: The State of Privacy & Location Marketing
20th Jan 202011:41 amRNSIssue of Equity and Total Voting Rights
15th Jan 20202:00 pmRNSTrading Update and Partnership with X-Mode
17th Dec 20199:00 amRNSHolding(s) in Company
17th Dec 20198:56 amRNSHolding(s) in Company
12th Nov 20192:45 pmRNSMello London 2019 Presentation
28th Oct 201911:00 amRNSLocation Sciences to present at Mello London 2019
28th Oct 20198:57 amRNSLocation Sciences to present at Mello London 2019
7th Oct 20194:12 pmRNSHolding(s) in Company
7th Oct 20194:09 pmRNSHolding(s) in Company
27th Sep 201911:18 amRNSResult of Placing
26th Sep 20196:24 pmRNSUpdate re Placing
26th Sep 20197:01 amRNSProposed Placing
26th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSContract with Vicinity Media
5th Sep 20197:00 amRNSPartnership with Blis
2nd Sep 20199:29 amRNSAdvisory Panel Appointment
1st Aug 20198:31 amRNSTrading Update and Appointment
15th Jul 20197:00 amRNSLocation Sciences appoints Andy Roberts
24th Jun 20191:38 pmRNSDirector's Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.